These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 36705756)
21. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
22. Letter to the Editor Regarding: What Triggers Takotsubo After a SARS-CoV-2 Vaccination? Heart Lung Circ. 2021;30(12):e119-20. Finsterer J; Stollberger C Heart Lung Circ; 2022 May; 31(5):e76-e77. PubMed ID: 35063380 [No Abstract] [Full Text] [Related]
23. [COVID-19 vaccines increase the risk of anaphylaxis]. Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103 [No Abstract] [Full Text] [Related]
24. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. Schulze-Koops H; Specker C; Skapenko A RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439 [TBL] [Abstract][Full Text] [Related]
25. Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible. Finsterer J Korean J Radiol; 2022 Jul; 23(7):773-774. PubMed ID: 35695321 [No Abstract] [Full Text] [Related]
26. The COVID antivaccination dilemma. Pederson T FASEB J; 2021 Nov; 35(11):e21953. PubMed ID: 34591331 [No Abstract] [Full Text] [Related]